FSMDX
Price
$33.93
Change
-$0.17 (-0.50%)
Updated
Sep 20 closing price
GVCCX
Price
$6.98
Change
-$0.03 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

FSMDX vs GVCCX

Header iconFSMDX vs GVCCX Comparison
Open Charts FSMDX vs GVCCXBanner chart's image
Fidelity Mid Cap Index
Price$33.93
Change-$0.17 (-0.50%)
VolumeN/A
CapitalizationN/A
Gabelli Value 25 C
Price$6.98
Change-$0.03 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FSMDX vs GVCCX Comparison Chart
Loading...
VS
FSMDX vs. GVCCX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and GVCCX is a Buy.

FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 35.8B vs. GVCCX (219M). FSMDX pays higher dividends than GVCCX: FSMDX (1.28) vs GVCCX (0.00). FSMDX was incepted earlier than GVCCX: FSMDX (13 years) vs GVCCX (25 years). FSMDX is a more actively managed with annual turnover of: 9.00 vs. GVCCX (6.00). FSMDX has a lower initial minimum investment than GVCCX: FSMDX (0) vs GVCCX (1000). FSMDX annual gain was more profitable for investors over the last year : 27.48 vs. GVCCX (6.24). FSMDX return over 5 years is better than : 57.97 vs. GVCCX (-35.79).
FSMDXGVCCXFSMDX / GVCCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years25 years-
Gain YTD13.33211.146120%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets35.8B219M16,347%
Annual Yield % from dividends1.280.00-
Returns for 1 year27.486.24440%
Returns for 3 years13.12-33.66-39%
Returns for 5 years57.97-35.79-162%
Returns for 10 years119.83-58.61-204%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMFG12.870.16
+1.26%
Sumitomo Mitsui Financial Group
KTCC5.240.02
+0.38%
Key Tronic Corp
DDS368.160.65
+0.18%
Dillards
JSPR23.88-0.03
-0.13%
Jasper Therapeutics
AHCO11.25-0.05
-0.44%
AdaptHealth Corp